5 years after COVID began, outstanding fines mean marginalised Australians are still paying the highest price
Our efforts in tackling neglected tropical diseases
Consequences of COVID-19 linger five years on
Burnet collaborators recognised in Australia Day honours
Research Reports + Policy Briefs
IMPACT Magazine
Events
Research Articles
How Science Matters Podcast
Study at Burnet
Synthesising enablers and barriers to hepatocellular carcinoma surveillance-A sy...
Partnership-Based Approach to Infectious Disease Research in Papua New Guinea (B...
Facilitators, barriers and acceptability of malaria reactive surveillance and re...
Towards a cure for long COVID: the strengthening case for persistently replicati...
Vaccines
Diagnostics
Therapeutics
Antibody Platforms
Australia
Papua New Guinea
Myanmar
People of Burnet
Leadership
Burnet Partners
Board Members
Appeals
Monthly Giving
Trusts + Foundations
Corporate Supporters
Giving in Wills + Bequests
Supporter Stories
About Us
Careers
History
Annual + Financial Reports
Palmer CS, Crowe SM
Journal AIDS (London, England)
Published 09 Aug 2018
Volume 30
ISSUE 18
Pagination 2895-2896
DOI 10.1097/QAD.0000000000001114